No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
LSL Pharma Trims Fiscal Q3 Net Loss
LSL Pharma Group Says Secures $1.4 Million in New Orders, Completes Steri-Med Production Scale Up
LSL Pharma Group Q2 Net Loss Halves, While Revenue Jumps 106%
Press Release: LSL PHARMA GROUP REPORTS RECORD REVENUES FOR THE SECOND QUARTER 2024
LSL Pharma Group Announces Voting Results of Its Annual and Special Meeting of Shareholders
LSL Pharma Group Raises $1.5-million in the First Tranche of a Private Placement of Share Units